Feedback / Questions
emactuzumab (RG7155) - SynOx Therap
https://www.globenewswire.com/news-release/2025/08/05/3127204/0/en/SynOx-Therapeutics-Completes-Enrollment-in-Registrational-Phase-3-TANGENT-Clinical-Trial-Significantly-Ahead-of-Timeline.html
Aug 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next